| Document Date: 2012-01-27 02:10:13
Open Document File Size: 701,06 KBShare Result on Facebook
Company Pfizer / MedImmune / Protein Databank / Phylogica / Amp / Mimotopes Pty Ltd / Ligand / Nexigen GmBH / Janssen / Roche / / Country Germany / / / Event Business Partnership / / IndustryTerm optimization technologies / biotechnology / target validation tools / pharmaceutical / extension technologies / / MedicalCondition Pseudomonas / pneumonia / Bordetella pertussis / disease / gram-positive bacterium S. aureus / rheumatoid arthritis / stroke / traumatic brain injury / resistant nosocomial infections / nosocomial infections / inflammation / / Person Paul Watt / / / Position Prime Minister / CFO and VP Corporate Development www.phylogica.com / CEO / reporter / / Product Phylomer / Ampicillin / / Region Western Australia / / Technology pharmacokinetics / biopharmaceuticals / DRUG DISCOVERY / phage display / optimization technologies / biotechnology / half-life extension technologies / / URL www.phylogica.com / /
SocialTag |
HARNESSING NATURAL DIVERSITY FOR DRUG DISCOVERY Structurally diverse libraries for drug discovery Opportunity • Phylogica uses synthetic biology to discover novel peptide-based biopharmaceuticals